Patent · US Active

BACE1 inhibitors

US11447478B2 · kind B2 · utility

0Cited by

1References

24Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Hans Hilpert · Reinach, CH
Roland Humm · Auggen, DE
Thorsten Muser · Soest, DE
Christian Schnider · Basel, CH
Roger Wermuth · Sissach, CH
Thomas Woltering · Freiburg (Elbe), DE

Key dates

Filing date	Apr 8, 2014
Grant date	Sep 20, 2022
Priority date	—
Expiry date	Sep 8, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides a compound of formula I having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.